Pilocarpine - Glaukos Corporation
Alternative Names: GLK-301; GLK-302; Pilocarpine cream formulation - Glaukos CorporationLatest Information Update: 13 Jan 2023
At a glance
- Originator Glaukos Corporation
- Class Alkaloids; Antiglaucomas; Eye disorder therapies; Furans; Imidazoles; Ketones; Miotics; Small molecules
- Mechanism of Action Muscarinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Dry eyes; Presbyopia